VERA Vera Therapeutics Inc

$22.57

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California.

Website: https://veratx.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1831828
Address
170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, US
Valuation
Market Cap
$1.36B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
2.35
Performance
EPS
$-2.75
Dividend Yield
—
Profit Margin
0.00%
ROE
-44.80%
Technicals
50D MA
$27.16
200D MA
$37.17
52W High
$51.61
52W Low
$18.53
Fundamentals
Shares Outstanding
64M
Target Price
$64.23
Beta
1.27

VERA EPS Estimates vs Actual

● Estimated
● Actual

VERA News & Sentiment

Aug 08, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BRISBANE, Calif., Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( Nasdaq: VERA ) today announced that, on August 4, 2025, the Compensation Committee of Vera's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 99,000 shares of Class A ...
Aug 06, 2025 • Motley Fool SOMEWHAT-BULLISH
Vera ( VERA ) Q2 Net Loss Widens 127%
Vera Therapeutics ( NASDAQ:VERA ) , a biotechnology company developing treatments for serious immunologic diseases, released results for the quarter on August 5, 2025. The most notable news was its widening net loss to $76.5 million, or $1.20 per share ( GAAP ) , compared to analyst expectations ...
Aug 04, 2025 • Benzinga SOMEWHAT-BULLISH
This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Allogene Therapeutics ( NASDAQ:ALLO ) , AvalonBay Communities ( NYSE:AVB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Brian Cheng downgraded the rating for Allogene Therapeutics, Inc.
Jul 10, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BRISBANE, Calif. , July 10, 2025 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( Nasdaq: VERA ) today announced that on July 6, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 133,500 shares of Class A common stock and restricted ...
Jun 09, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BRISBANE, Calif., June 09, 2025 ( GLOBE NEWSWIRE ) -- Vera Therapeutics, Inc. ( Nasdaq: VERA ) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 124,000 shares of Class A common stock and restricted ...
Jun 06, 2025 • Benzinga SOMEWHAT-BULLISH
Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results - ABM Indus ( NYSE:ABM ) , Docusign ( NASDAQ:DOCU )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 1% on Friday. The Dow traded up 1.05% to 42,765.32 while the NASDAQ gained 1.31% to 19,551.81. The S&P 500 also rose, gaining, 1.10% to 6,004.74. In trading on Friday, utilities stocks fell by 0.2%.
Sentiment Snapshot

Average Sentiment Score:

0.116
50 articles with scored sentiment

Overall Sentiment:

Neutral

VERA Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.72
  • Estimate: $-0.73
  • Whisper: —
  • Surprise %: 1.4%
Nov 07, 2024
Sep 30, 2024 (Pre market)
-0.23 Surprise
  • Reported EPS: $-0.85
  • Estimate: $-0.62
  • Whisper: —
  • Surprise %: -37.5%
Aug 08, 2024
Jun 30, 2024 (Pre market)
-0.06 Surprise
  • Reported EPS: $-0.62
  • Estimate: $-0.56
  • Whisper: —
  • Surprise %: -10.7%
May 09, 2024
Mar 31, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $-0.56
  • Estimate: $-0.53
  • Whisper: —
  • Surprise %: -5.7%
Mar 20, 2024
Dec 31, 2023 (Pre market)
-0.09 Surprise
  • Reported EPS: $-0.60
  • Estimate: $-0.51
  • Whisper: —
  • Surprise %: -17.6%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.53
  • Whisper: —
  • Surprise %: 15.1%
Aug 10, 2023
Jun 30, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $-0.46
  • Estimate: $-0.69
  • Whisper: —
  • Surprise %: 33.3%
May 11, 2023
Mar 31, 2023 (Pre market)
-0.2 Surprise
  • Reported EPS: $-0.80
  • Estimate: $-0.60
  • Whisper: —
  • Surprise %: -33.3%
Mar 28, 2023
Dec 31, 2022 (Pre market)
-0.28 Surprise
  • Reported EPS: $-1.18
  • Estimate: $-0.90
  • Whisper: —
  • Surprise %: -31.1%

Financials